• BSE
  • NSE
    • {{d.cmpname}}
    • {{d.price}}
    • ({{d.PerChg}}%)
Market | Equity | Daily Market Tracker | IPO Synopsis
IPO SYNOPSIS
Earum Pharmaceuticals Ltd
Registered Office:
G1 Ground Floor VR Complex,Nr Sanathal Cross Rd SP RingRd,
Ahmedabad - 382210,
Gujarat, India.
Initial Public Offer of 18,48,000 equity shares of face value of (Rs)10 each (the "equity shares") of Earum Pharmaceuticals Limited ("the company" or "epl" or "the issuer") at an issue price of (Rs)36 per equity share for cash, aggregating up to (Rs) 6.65 Crores ("public issue") out of which 96,000 equity shares of face value of (Rs) 10 each, at an issue price of (Rs) 36 per equity share for cash, aggregating (Rs) 0.35 Crores will be reserved for subscription by the market maker to the issue (the "market maker reservation portion"). the public issue less market maker reservation portion i.e. issue of 17,52,000 equity shares of face value of (Rs) 10 each, at an issue price of (Rs) 36 per equity share for cash, aggregating upto (Rs) 6.31 Crores is here in after referred to as the "net issue". the public issue and net issue will constitute 29.96% and 28.41 % respectively of the post issue paid-up equity share capital of the company. The face value of the equity share is (Rs)10 each. Fixed Price issue at (Rs)36 per share and is 3.6 times of the face value.
Issue
Money Payable On
Opens On
Closes On
Application
Allotment
21-Jun-19
26-Jun-19
36.00-0.00
0.00-0.00
Minimum Application for shares in Nos : 3000     Further Multiples of : 3000
 
(Rs.Cr)
Lead Managers to the Issue
Project Cost
6.65
Hem Securities Ltd
Project Financed
6.65
 
Post Issue
6.17
 
Issue Price
36.00
 
Projects
To Meet Working Capital Requirements
General Corporate Purpose
Promoted By
Bhumishth Narendrabhai Patel
Payal Bhumishth Patel
Listing At
BSE - SME
Registrar to the Issue
Bigshare Services Pvt Ltd
DB (International) Stock Brokers Limited: SEBI Reg. No.-INZ000179035 / CDSL : IN-DP-CDSL-266-2004 MCX-SX:INE 260643233/21500(CD)
Daga Commodities Private Limited: SEBI Reg. No. INZ000028833
Investor Grievances Email ID: compliance@dbonline.in & investors@dbonline.in
Copyright © 2016 All rights Reserved DB (International) Stock Brokers Ltd.     Designed, Developed and content powered by C-MOTS Infotech( ISO 9001:2015 certified )
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."         "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors."          "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Attention Investors ::
subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries